Global Chloromethyl Isopropyl Carbonate (CMIC) Market (Value, Volume) – Analysis By Application, Type, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)
Executive Summary Global Chloromethyl Isopropyl Carbonate Market (CMIC) valued at USD 26.67 Million and xx Metric Tonnes by volume in the year 2020, form an integral part of the important ingredients of the pharmaceutical industry. Chloromethyl Isopropyl Carbonate is one major chemical that is used commonly for making drugs to fight AIDS virus and other diseases like Hepatitis B. In fact, it is a key component of the drug Tenofovir that is useful to cure Hepatitis. A number of companies use this pharma intermediate or specialty chemical for curing chronic diseases like AIDS and hepatitis B.
Chloromethyl Isopropyl Carbonate is mainly used in pharmaceutical industry as key intermediate for anti-AIDS and anti-hepatitis B drug Tenofovir. There are also many chemicals which are used for manufacturing of Anti-Retroviral. During the pandemic situation caused by the COVID-19, consumption of anti-viral medicines have grown in general, resulting in favourable situation for raw material producers of these drugs including companies manufacturing Chloromethyl Isopropyl Carbonate and other chemicals used in manufacturing of Anti-Viral Drugs.
Asia Pacific dominates the Chloromethyl Isopropyl Carbonate Market on account of the increasing demand for the antiviral drugs because of the growing elderly population in the region that are more prone to contracting viral diseases. The market uptake of antiviral drugs is influenced by favourable regulatory policies and initiatives taken by the government.
Moreover, the increasing investment and funding by the government and private organizations in developing countries such as China and India encourages new market entrants. Major biopharmaceutical firms in the Asia Pacific region are focusing on the development of host-targeting antiviral medicines. AbbVie Inc., Gilead Sciences, Merck & Co., Bristol-Myers Squibb, GSK and Aurobindo Pharma Ltd. are among major competitors in Asia Pacific antiviral drugs market. To establish a presence in the region, these organizations are pursuing various market tactics such as cooperation, product innovation, mergers, and acquisitions.
Scope of the Report • The report presents the analysis of Chloromethyl Isopropyl Carbonate Market for the historical period of 2016-2020 and the forecast period of 2021-2026.
• The report analyses Chloromethyl Isopropyl Carbonate Market By Value and By Volume (By Production).
• The report analyses Chloromethyl Isopropyl Carbonate Market By Application (Human Immunodeficiency Virus Intermediates, Hepatitis B Virus Intermediates and Others).
• The report further assesses the Chloromethyl Isopropyl Carbonate Market By Type (Purity 98% and Others).
• The Global Chloromethyl Isopropyl Carbonate has been analysed By Region (North America, Europe and Asia Pacific) and By Country (United States, Canada, Germany, United Kingdom, China and India).
• The key insights of the report have been presented through the frameworks of Major Mergers & Acquisitions. Also, the attractiveness of the market has been presented By Region, By Application and By Type. Additionally, trends, drivers and challenges of the industry has been analysed in the report.
• The companies analysed in the report include Chemcon Speciality Chemicals Limited, Paushak, Atul Ltd., Anshul Specialty Molecules Private Limited, Santa Cruz Biotechnology and Pingyuan Xinda Chemical Co.,Ltd.
Key Target Audience
• Healthcare and Pharmaceutical Companies
• Traders, Importers, and Exporters
• Raw Material Suppliers and Distributors
• Government and Research Organisations
• Consulting and Advisory Firms
• Investment Banks and Equity Firms
Our reports have been used by over 10K customers, including:
The healthcare analytical testing services market is projected to reach USD 9.8 billion by 2026 from USD 5.6 billion in 2021, at a CAGR of 11.9%. Growth in the market is driven by the rising trend of outsourcing of analytical testing by pharmaceutical companies and medical device companies, an increasing number of clinical trials, and the...
Generics Global Industry Almanac - Market Summary, Competitive Analysis and Forecast to 2025 Summary Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2016-20, and forecast to 2025). The profile also contains...
The European Pharmaceutical Logistics Market is expected to grow at a CAGR of more than 4% during the forecast period. The market growth can be seen as a result of Covid-19, with an increase in pharmaceutical product imports (USD 361 billion) and exports (USD 524 billion) in the year 2020. Logistics is an essential segment of supply...
The global pharmaceutical CMO market was valued at USD 120.29 billion in 2020, and it is expected to reach USD 195.70 billion by 2026, registering a CAGR of 7.85% from 2021 to 2026. COVID-19 pandemic has had a beneficial effect on contract manufacturing services overall. There were multiple opportunities for CMOs in clinical trial manufacturing,...
Real-world data and real-world evidence are used to monitor the post-market safety and adverse events of drugs.The monitoring of this data assists in making regulatory decisions. The healthcare community is using RWE and RWD to support coverage decisions and to develop guidelines and decision support tools for use in clinical practice. The...
The global pharmaceutical contract development and manufacturing market is projected to reach USD 171.3 billion by 2026 from USD 120.6 billion in 2021, at a CAGR of 7.3% during the forecast period. Market growth is driven mainly by factors such as rising demand for generics, increasing investments in pharmaceutical R&D, and investments in...
The market for dust control systems and suppression chemicals is valued at USD 12,350 million in 2020 and is expected to grow at a CAGR of more than 4% during the forecast period. Restrictions by governments in various countries due to the spread of COVID-19 have placed difficulties on mining companies operating in affected countries....
Executive Summary Global Hexamethyldisilazane Market was valued at USD 202.32 Million and xx Kilotonne by volume in the year 2020. Hexamethyldisilane (HMDS) is an organosilicon compound used as a reagent or precursor to bases and is primarily used as a silylating agent in the process of manufacturing pharmaceutical drugs...
The pharmaceutical isolator market was valued at 5,966.07 million in 2021 and is projected to reach US$ 10,560.30 million by 2028; it is expected to grow at a CAGR of 8.5 % from 2021 to 2028. The growth of the pharmaceutical isolator market is attributed to factors such as an increase in investments by the pharmaceutical and biotechnology...
The global single-use bioreactors market is projected to reach USD 8.8 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 21.1% during the forecast period. Increasing adoption of SUBs among small companies and startups, reduced automation complexity, ease in the cultivation of marine organisms, reduced energy and water consumption,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.